Q3 2020 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript
Ladies and gentlemen, welcome to the Sobi presentation of the Q3 results. (Operator Instructions)
I'll now hand over to Guido Oelkers, CEO. Please begin your meeting.
()-&
Yes. Thank you so much. Welcome, everybody. It's really my pleasure to welcome you to the Q3 earnings call. As per usual, I'll go straight into forward-looking statement as we have disclosed at many of these events.
I'm joined today by Henrik, our CFO; and the first time by Ravi, who is our new Head of R&D and CMO. And what we'd like to share with you is a little bit the journey and what we -- and bring the numbers a little bit alive, so that you can share our excitement around the company.
I'll go straight into the ongoing transformation. I mean when you think about maybe step -- quick step back where we are today, I think we have built quite a significant diversified portfolio into Haematology and Immunology. Our 2 core areas, as you will see
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
